Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biologics for severe asthma and beyond
Carlo Mümmler, Katrin Milger
Pharmacology & Therapeutics (2023) Vol. 252, pp. 108551-108551
Closed Access | Times Cited: 9

Showing 9 citing articles:

Clinical remission in severe asthma: lights and shadows on an ambitious goal
Corrado Pelaia, Eleonora Zannoni, Giovanni Paoletti, et al.
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 24, Iss. 4, pp. 230-236
Closed Access | Times Cited: 5
Real-World Data on Tezepelumab in Patients With Severe Asthma in Germany
Leonie Biener, Carlo Mümmler, Christopher Alexander Hinze, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 9, pp. 2399-2407.e5
Closed Access | Times Cited: 5
Novel biomarkers in asthma
Nikita Agrawal, Monica Kraft
Current Opinion in Pulmonary Medicine (2025)
Closed Access
Eosinophil-Driven vs. Eosinophil-Associated Severe Asthma: Practical Implications for Target Treatment
Valentina D’Aiuto, Ilaria Mormile, Francescopaolo Granata, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1729-1729
Open Access
The impact of biologic therapy on work capacity and workforce attachment in patients with severe asthma
Kjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
Journal of Asthma (2025), pp. 1-11
Closed Access
First-in-human study on tolerability, pharmacokinetics and pharmacodynamics of single and multiple escalating doses of XKH001, a recombinant humanized monoclonal antibody against IL-25 in healthy Chinese volunteers
Hong Zhang, Wen-Bo Zheng, Ran Peng, et al.
Expert Opinion on Investigational Drugs (2025), pp. 1-7
Closed Access
Long-term safety, durability of response, cessation and switching of biologics
Arjun Mohan, Anna Y. Qiu, Njira Lugogo
Current Opinion in Pulmonary Medicine (2024) Vol. 30, Iss. 3, pp. 303-312
Closed Access | Times Cited: 2
Real-World and Patient-Reported Outcomes of Dupilumab and Other Biological Drugs for Chronic Obstructive Pulmonary Disease—A Systematic Review
Ophir Freund, Ori Wand, Sara Kutzkel, et al.
Diagnostics (2024) Vol. 14, Iss. 21, pp. 2390-2390
Open Access | Times Cited: 2
A systematic review of the role of surfactants in bronchial asthma: Implications for pathogenesis and treatment of the disease
I. Ismailov
Gaceta Médica de Caracas (2024) Vol. 132, Iss. Supl. 1
Open Access | Times Cited: 1
Page 1

Scroll to top